close

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.91
+4.64 (2.26%)
AAPL  272.14
+5.96 (2.24%)
AMD  216.08
+19.48 (9.91%)
BAC  50.84
-0.23 (-0.46%)
GOOG  310.70
-0.99 (-0.32%)
META  640.24
+2.99 (0.47%)
MSFT  387.33
+2.86 (0.75%)
NVDA  193.01
+1.46 (0.76%)
ORCL  146.65
+5.34 (3.78%)
TSLA  406.17
+6.34 (1.58%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today